Profound Medical Corp.

NasdaqCM:PROF Stock Report

Market Cap: US$194.3m

Profound Medical Past Earnings Performance

Past criteria checks 0/6

Profound Medical's earnings have been declining at an average annual rate of -12.8%, while the Medical Equipment industry saw earnings growing at 11.5% annually. Revenues have been growing at an average rate of 10.4% per year.

Key information

-12.8%

Earnings growth rate

-0.06%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate10.4%
Return on equity-70.3%
Net Margin-350.1%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Profound Medical Q2 GAAP EPS beats, revenue in-line

Aug 04

Profound Medical Lacks Conviction To Overthrow Macro Headwinds

Jul 10

Revenue & Expenses Breakdown

How Profound Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:PROF Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 248-282016
31 Mar 247-281914
31 Dec 237-291914
30 Sep 236-291713
30 Jun 237-291715
31 Mar 237-271815
31 Dec 227-291815
30 Sep 226-292016
30 Jun 227-302016
31 Mar 228-311915
31 Dec 217-311815
30 Sep 219-281613
30 Jun 218-281413
31 Mar 217-261311
31 Dec 207-221210
30 Sep 207-181210
30 Jun 205-17119
31 Mar 204-161010
31 Dec 194-1589
30 Sep 193-1579
30 Jun 193-1479
31 Mar 193-1478
31 Dec 182-1588
30 Sep 182-1688
30 Jun 183-1678
31 Mar 184-1578
31 Dec 174-1578
30 Sep 172-1588
30 Jun 171-1467
31 Mar 170-1257
31 Dec 160-1247
30 Sep 160-1146
30 Jun 160-1046
31 Mar 160-1455
31 Dec 150-1254
30 Sep 150-1253
30 Jun 150-1243
31 Mar 150-822
31 Dec 140-722

Quality Earnings: PROF is currently unprofitable.

Growing Profit Margin: PROF is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PROF is unprofitable, and losses have increased over the past 5 years at a rate of 12.8% per year.

Accelerating Growth: Unable to compare PROF's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PROF is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (7.9%).


Return on Equity

High ROE: PROF has a negative Return on Equity (-70.32%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies